| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.86 |
| Vanguard Group, Inc. (Subfiler) | 8.67 |
| The Vanguard Group, Inc. | 8.29 |
| State Street Corp. | 4.42 |
| Vanguard Total Stock Market ETF | 3.13 |
| BlackRock Fund Advisors | 2.97 |
| Vanguard 500 Index Fund | 2.41 |
| Capital Research & Management Co. (International Investors) | 2.40 |
| BlackRock Institutional Trust Co. NA | 2.22 |
| JPMorgan Investment Management, Inc. | 2.20 |
| Geode Capital Management LLC | 2.05 |
| Capital Research & Management Co. (Global Investors) | 1.81 |
| Charles Schwab Investment Management, Inc. | 1.29 |
| Fidelity 500 Index Fund | 1.15 |
| Norges Bank (13F) | 1.06 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 30'000 | 30'000 | 47'000 | 50'000 | 50'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.09 | 1.11 | 0.97 | 1.12 | 1.16 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 16'945 | 49'519 | 24'173 | 27'928 | 28'463 |
| Summe Anlagevermögen | 31'864 | 58'916 | 100'139 | 92'983 | 81'445 |
| Summe Aktiva | 59'352 | 89'115 | 150'565 | 146'529 | 138'805 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 40'310 | 67'088 | 87'063 | 77'575 | 64'191 |
| Summe Fremdkapital | 67'798 | 97'287 | 137'468 | 131'093 | 121'518 |
| Summe Eigenkapital | -8'446 | -8'172 | 13'097 | 15'436 | 17'287 |
| Summe Passiva | 59'352 | 89'115 | 150'565 | 146'529 | 138'805 |
Adresse
| 1 North Waukegan Road, 60064-6400 North Chicago | |
| Telefon | +1 (847) 932-7900 |
| URL | http://www.abbvie.com |
Management
|
Azita Saleki-Gerhardt
Executive Vice President-Operations |
|
Brett J. Hart
Independent Director |
|
Brian L. Durkin
Vice President |
|
Carrie Strom
Senior VP & President-Global Allergan Aesthetics |
|
Chris Boone
Vice President & Global Head-Health Economics |
|
Edward J. Rapp
Independent Director |
|
Esteban Plata
Vice President-Western Europe & Canada |
|
Frederick H. Waddell
Independent Director |
|
Glenn Fletcher Tilton
Lead Independent Director |
|
Jeffrey Ryan Stewart
Chief Commercial Officer & Executive VP |
|
Jennifer L. Davis
Independent Director |
|
Katherine Rielly-Gauvin
Vice President-Global Commercial Development |
|
Kevin K. Buckbee
Senior Vice President & Controller |
|
Liz Shea
Head-Investor Relations |
|
Melody B. Meyer
Independent Non-Executive Director |
|
Perry C. Siatis
Secretary, Executive VP & General Counsel |
|
Rebecca Brown Roberts
Independent Director |
|
Richard A. Gonzalez
Chairman & Chief Executive Officer |
|
Robert A. Michael
Vice Chairman, President & Chief Operating Officer |
|
Robert J. Alpern
Independent Director |
|
Roxanne Schuh Austin
Independent Director |
|
Scott T. Reents
Chief Financial Officer & Executive Vice President |
|
Susan E. Quaggin
Independent Director |
|
Thomas C. Freyman
Independent Director |
|
Thomas J. Hudson
Chief Scientific Officer, Senior VP-R&D |
|
Timothy J. Richmond
Chief Human Resources Officer & Executive VP |
|
Todd D. Bosse
Vice President-Investor Relations |
|
William H. L. Burnside
Independent Director |